ArticleInternational journal of molecular sciences2025
Synthesis and Evaluation of Powerful Antioxidant Dendrimers Derived from D-Mannitol and Syringaldehyde.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correction: Agbemade et al. Synthesis and Evaluation of Powerful Antioxidant Dendrimers Derived from D-Mannitol and Syringaldehyde.International journal of molecular sciences · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
Abstract
Antioxidants play a crucial role in preventing oxidative damage and are therefore integral to various sectors, including healthcare, food preservation, cosmetics, and industrial applications. Their capacity to enhance overall health and improve the quality and shelf life of products in these domains underscores their significance. Two powerful antioxidant dendrimers were synthesized using D-mannitol as the core and syringaldehyde as the antioxidant-producing phenolic unit. The generation 1 (G1) dendrimer features 12 syringic units on its surface, while the generation 2 (G2) dendrimer has 24. Antioxidant capacities were assessed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) and the β-carotene bleaching assays. Based on IC50 values, the G2 (0.7 μM) and G1 (1.36 μM) dendrimers show 371- and 191-fold higher antioxidant activity, respectively, compared to the starting compound, syringaldehyde (260 μM). They are also 1251- and 647-times more effective than butylated hydroxytoluene (BHT) (880 μM). Overall, G2 is twice as potent as G1. The dendrimers also provide strong protection against β-carotene bleaching. At concentrations between 3.75 and 60 μM, G2 preserves 75% to 88% of β-carotene after 16 h at 45 °C, while G1 maintains 51% to 84%. In comparison, syringaldehyde and BHT provide significantly less protection, with ranges of 21% to 47% and 22% to 36%, respectively. Their greatly enhanced antioxidant capabilities are due to the numerous free-radical-scavenging sites created by phenolic hydroxyl groups, which have electron-donating groups at the
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.